Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Monday.com | MNDY | Nov 22, 2024 | 284.59 | +3.02 |
Mondee | MOND | Nov 22, 2024 | 0.99 | +1.21 |
Mondelez International A | MDLZ | Nov 22, 2024 | 64.40 | -0.60 |
Moneyhero | MNY | Nov 22, 2024 | 1.15 | 0.00 |
MoneyLion A | ML | Nov 22, 2024 | 87.18 | +8.65 |
MongoDB A | MDB | Nov 22, 2024 | 332.50 | +5.41 |
Monogram Technologies | MGRM | Nov 22, 2024 | 1.97 | -0.51 |
Monolithic Power Systems | MPWR | Nov 22, 2024 | 580.81 | +1.46 |
Monopar Therapeutics | MNPR | Nov 22, 2024 | 20.10 | +1.98 |
Monro | MNRO | Nov 22, 2024 | 27.04 | +1.16 |
Monroe Capital | MRCC | Nov 22, 2024 | 8.41 | -0.36 |
Monster Beverage | MNST | Nov 22, 2024 | 54.06 | +0.15 |
Montauk Renewables | MNTK | Nov 22, 2024 | 4.46 | +0.68 |
Monte Rosa Therapeutics | GLUE | Nov 22, 2024 | 8.49 | +1.68 |
Montrose Environmental Group | MEG | Nov 22, 2024 | 17.89 | -4.94 |
Moodys | MCO | Nov 22, 2024 | 480.66 | +0.57 |
Moog A | MOG-A | Nov 22, 2024 | 222.56 | +1.02 |
Moog B | MOG-B | Nov 22, 2024 | 214.95 | 0.00 |
Moolec Science | MLEC | Nov 22, 2024 | 0.89 | +4.58 |
MoonLake Immunotherapeutics | MLTX | Nov 22, 2024 | 54.32 | +4.74 |
Morgan Stanley | MS | Nov 22, 2024 | 134.69 | -0.22 |
Morgan Stanley China A Share Fund | CAF | Nov 22, 2024 | 12.32 | -2.95 |
Morgan Stanley Direct Lending Fund | MSDL | Nov 22, 2024 | 20.43 | -0.97 |
Morgan Stanley Emerging Markets Debt Fund | MSD | Nov 22, 2024 | 7.70 | +0.46 |
Morgan Stanley Emerging Markets Domestic Debt Fund | EDD | Nov 22, 2024 | 4.61 | 0.00 |
Morgan Stanley FXDFR Pref | MS-K | Nov 22, 2024 | 25.16 | -0.04 |
Morgan Stanley India Investment Fund | IIF | Nov 22, 2024 | 27.90 | +1.68 |
Morgan Stanley Pref A | MS-A | Nov 22, 2024 | 23.63 | +0.55 |
Morgan Stanley Pref E | MS-E | Nov 22, 2024 | 25.34 | 0.00 |
Morgan Stanley Pref F | MS-F | Nov 22, 2024 | 25.32 | -0.04 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.